StockData
iRhythm Holdings, Inc. logo

iRhythm Holdings, Inc. (IRTC) stock

IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/301% below fair value
$89.67−1.16 (-1.28%)

Close on Nov 17, 2026Market cap $2.96BP/E –Yield –

iRhythm Holdings, Inc. grew revenue 25.6% to $825.34M over the twelve months to Jun 30, 2026. Free cash flow was $38.98M, up 39.8% from a year earlier. At the latest close the market valued the company at $2.96B.

Revenue
$825.34M
+25.6% vs. a year earlier
Operating income
-$24.87M
TTM Q2 2026
Free cash flow
$38.98M
+39.8% vs. a year earlier
EPS, diluted
-$0.43
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$2.96B
P/E ratio
–
Price to sales
3.58
Price to book
15.89
Dividend yield
–
Free cash flow yield
1.32%

Fundamentals

Revenue
$825.34M
Net income
-$13.95M
EPS, diluted
-$0.43
Free cash flow
$38.98M
Book value per share
$5.65
Diluted shares
33M

Trading

Next earnings
Feb 18, 2027 (estimated, after the close)
Previous close
$90.83
Open
$90.52
Day's range
$89.35 – $92.03
Volume
590,216
Average volume (20 days)
1,012,686
Index membership
Russell 2000, Russell 3000
52-week range
$82.85 – $192.47
RSI (14 days)
34.7
Volatility (1 year)
53.9%
Relative volume
1.08×

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2016, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.

PeriodIRTCS&P 500DifferenceIRTC per yearS&P 500 per year
1 month-17.5%-4.0%−13.4 pts
3 months-23.3%-5.0%−18.3 pts
Year to date-49.5%+8.2%−57.7 pts
1 year-46.5%+11.2%−57.7 pts
3 years+10.1%+68.5%−58.4 pts+3.3%+19.0%
5 years-18.6%+67.3%−85.9 pts-4.0%+10.8%
10 years+226.6%+291.6%−65.0 pts+12.6%+14.6%

Thirteen years at a glance

Fiscal years 2013 to 2025 and trailing twelve months, USD

Revenue

$825.34M+25.6% YoY

Gross profit

$589.74M+28.6% YoY

Operating income

-$24.87M

Net income

-$13.95M

EPS, diluted

-$0.43

Free cash flow

$38.98M+39.8% YoY
Reported periodTrailing twelve months

Press releases

Releases iRhythm filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About iRhythm

Surgical & Medical Instruments & Apparatus

iRhythm is a digital healthcare company providing device-based technology for ambulatory cardiac monitoring. Its offerings combine wearable, patch-based biosensors with cloud-based data analytic software to monitor patients and assist in diagnosing arrhythmias, such as atrial fibrillation. Key systems include the Zio monitor, Zio XT, and Zio AT systems, which support long-term continuous monitoring and mobile cardiac telemetry services. Customers and users primarily comprise physicians, cardiology practices, electrophysiologists, primary care clinicians, integrated delivery networks, and value-based healthcare organizations.

Company profile, executives and history

iRhythm stock: common questions

What is iRhythm's stock price?

IRTC closed at $89.67 on Nov 17, 2026, down 1.28% on the day. Over the past 52 weeks it traded between $82.85 and $192.47.

What is iRhythm's market cap?

iRhythm was worth $2.96B at the close on Nov 17, 2026: the share price times the diluted shares outstanding.

What is IRTC's P/E ratio?

iRhythm lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.43), so it has no meaningful P/E ratio.

How much revenue does iRhythm make?

iRhythm reported revenue of $825.34M for the twelve months to Jun 30, 2026, up 25.6% from a year earlier.

Does iRhythm pay a dividend?

No. iRhythm has not paid a cash dividend over the last twelve months.

When does iRhythm report earnings next?

iRhythm is expected to report Q4 FY2026 results on Feb 18, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has IRTC stock performed over the past year?

Including dividends, IRTC returned -46.5% over the past year, against +11.2% for the S&P 500.

How many IRTC shares are sold short?

3M shares were sold short at the latest FINRA report, 10.12% of the float, or 6.7 days of average trading volume.

Who are iRhythm's competitors?

Companies most similar to iRhythm by business, industry and size include ATRC, INSP, TNDM, NVCR, HTFL.

See a number that looks wrong?